Invention Grant
- Patent Title: Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
-
Application No.: US12229425Application Date: 2008-08-21
-
Publication No.: US08399496B2Publication Date: 2013-03-19
- Inventor: Alan Bruce Montgomery , Manfred Keller , Frank-Christophe Lintz
- Applicant: Alan Bruce Montgomery , Manfred Keller , Frank-Christophe Lintz
- Applicant Address: US CA Foster City
- Assignee: Gilead Sciences, Inc.
- Current Assignee: Gilead Sciences, Inc.
- Current Assignee Address: US CA Foster City
- Agency: Gilead Sciences, Inc.
- Main IPC: A61K31/426
- IPC: A61K31/426 ; A61K31/425 ; A61K31/15 ; A61K31/18
Abstract:
A method and a composition for treatment of pulmonary bacterial infections caused by gram-negative bacteria suitable for treatment of infection caused by Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, Pseudomonas aeruginosa, Haemophilus influenzae, Proteus mirabilis, Enterobacter species, Serratia marcescens as well as those caused by Burkholderia cepacia, Stenotrophomonas maltophilia, Alcaligenes xylosoxidans, and multidrug resistant Pseudomonas aeruginosa, using a concentrated formulation of aztreonam lysinate delivered as an aerosol or dry powder formulation.
Public/Granted literature
- US20090028801A1 Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections Public/Granted day:2009-01-29
Information query
IPC分类:
